ArticleNature communications2022

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

Juanjie Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.